Fuentes GL, Rodríguez RZ, Rodríguez PAD

Language: Spanish
References: 18
Page: 1197-1209
PDF size: 496.60 Kb.

ABSTRACT

Erythroderma is a more or less scaly erythematous rash that affects more than 90% of the body surface area. It is a disease capable of compromising the vital prognosis and that can be complicated by hydroelectrolytic imbalances, thermoregulation disorders, infections, as well as cardiovascular failure. In this publication we refer to the case of a 72-year-old male patient with a history of high blood pressure and leprosy who received polychemotherapy, is admitted to the dermatology service in the observation period, as about a year ago he began to develop redness of the skin and multiple scales. At the time of the examination, an erythrothermal patient, ectropion, important ungueal dystrophy, with axillary and inguinal palpable adenopathies, associated with a widespread intense itching, is observed. Studies are conducted for diagnosis including inguinal and skin node biopsy, the latter compatible with Mycosis Fungoide. Three erythrodermal variants are currently recognized in skin T-cell lymphoma: Sézary syndrome, Erythroderma in fungoid mycosis, and Erythroderma in skin T-cell lymphomas: Undepede. While Sézary syndrome is understood as a leukemia expression of erythrodermal T-cell skin lymphoma, with numerous Sézary cells in skin, blood and other tissues, Erythroderma in fungoid mycosis would be determined in the absence of these same haematological and histological findings before an erythrodermal clinical picture. It is necessary to publish the article by the form of presentation of fungoid mycosis, taking into account that this dermatosis has a number of differential diagnoses that makes it the great simulator in Dermatology.

REFERENCES

1. Zapata González A, Cerón García IA, Williams Jacquez ÁD. Eritrodermia difusa y crioglobulinemia concomitante con linfoma cutáneo primario anaplásico de células T CD30+, una asociación poco común. Dermatología Revista Mexicana 2020; 64(2): 176–82.

2. Maldonado García CA, Orozco Anahuati AP. Abordaje diagnóstico de la eritrodermia en el adulto. Rev Med Inst Mex Seguro Soc 2017; 55(3): 353–60.

3. Acosta LT, Del Río DY. Eritrodermia en niños. Rev Asoc Colomb Dermatol 2015; 23(2): 131–40.

4. Molgó M, Reyes Baraona F. Actualización en diagnóstico y manejo de micosis fungoide y síndrome de Sézary. Rev Chilena Dermatol 2015; 31(4): 338-353.

5. Reifs Alcántara CM, Salido Vallejo R, Garnacho Saucedo GM, Corte Sánchez S, González Menchen A, García Nieto AV. Alemtuzumab in refractory Sézary syndrome. An Bras Dermatol 2016; 91(5): 642-644.

6. Molgó M, Jaque A, Vial V, Ocqueteau M, Pereira J, Chang M, et al. Fotoféresis en el tratamiento de Síndrome de Sézary: Caso clínico. Rev Méd Chile 2015; 143(11): 1449-1458.

7. Piña Rodríguez Y, Piña Russinyol JJ, Hernández Fernández DM, Fernández Martori M, Darias Domínguez C. Síndrome de Sézary. Presentación de un caso. Rev Méd Electrón 2018; 40(2): 471-479.

8. Monzón Castillo EP, Tejada Martínez G, Oliva García AB. Micosis fungoide en vulva: Presentación de un caso. Rev. Peru. Ginecol. Obstet. 2018; 64(3): 489-494.

9. Malveira Braga MI, Pascoal G, Gamonal Lima SB, Castañon MC, Marques N. Folliculotropic micosis fungoide: challengingclinical, histopathological and immunohistochemical diagnosis. An. Bras. Dermatol 2017; 92(5): 73-75.

10. Thaís Braga C, Guimarães Ribeiro BI, Nayara Silveira M, Otávio Augusto P. Micose fungoide hipocromiante na infância: avaliação de um caso clínico. Rev Méd Minas Gerais 2018; 28: e-1943.

11. Rosero Arcos C, Madrigal Ramos C, Alvarado A V. Micosis fungoide ampollar de presentación en palmas y plantas. Revista Médica Vozandes 2017; 28(1): 57-60.

12. Porto AC, Blumetti TP, Mendes ASP, Duprat Neto JP, Rezze GG,Braga JCT. Mycosis fungoides: reflectance confocal microscopy and its role in the diagnosis. Appl. cancer res. 2018; 38(10): 1-4.

13. Junco Bonet M, Betancourt Betancourt G, Machado Garcia JL, LarquinComet JI. Micosis fungoide en estadio tumoral: presentación de un caso. AMC. 2016; 20(1): 44-49.

14. Ying-Yi L, Chieh-Hsin W, Chun-Ching L, Chien-Hui H. Hyperpigmentation as a peculiar presentation of mycosis fungoides. An Bras Dermatol. 2017; 92(5): 92-94.

15. Uh Sánchez I, Molina L, Lapizco A, Eljure-López N, Aceves Díaz JE. Eritrodermia asociada con adenocarcinoma gástrico. Dermatol Rev Mex 2018; 62(3): 242–6.

16. de Albuquerque Fernandes LS, Aguiar Costa F, Lima Barbosa R, Lupi Martins O. Mycosis fungoides precedin glymphomatoid papulosis. Medicina Ribeiräo Preto 2017; 50(4): 261-264.

17. Colmenares Roldán LM, Jiménez Sol B. Cuándo emplear PUVA o NB-UVB en micosis fungoide. CES Med 2016; 30(1): 55-65.

18. Bariani Prado MC, Fernando Fróes JL, Ribeiro Quinteiro AM, Carneiro de Souza S, Pereira Arantes T. Mycosis fungoides and Kaposi’s sarcoma association in an HIV-negativepatient. An Bras Dermatol 2016; 91(5): 108-110.